Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norcross

Showing results (161-170 of 483) with videos related to

Pageof 49
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2022
A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and ComprehensibilityAri Gnanasakthy, Lindsey Norcross, Carla DeMuro Romano, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 6, 2023
A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)Ari Gnanasakthy, Courtney Levy, Lindsey Norcross, et al.
FEBS Letters|July 8, 1985
A somatic cell mutant with a kinetically altered 3-hydroxy-3-methylglutaryl coenzyme A reductaseM Sinensky, J Logel, R Schnitzer-Polokoff, et al.
Journal of Virology|March 1, 1991
Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactionsL N Callahan, M Phelan, M Mallinson, et al.
Spine|May 20, 1999
Intraoperative somatosensory evoked potential findings in acute and chronic spinal canal compromiseK Norcross-Nechay, T Mathew, J W Simmons, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1992
Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4L N Callahan, G Roderiquez, M Mallinson, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
To let go or not to let go: how ParA can impact the release of the chromosomal anchoring in <i>Caulobacter crescentus</i>Stephanie G Puentes-Rodriguez, J D Norcross, Paola E Mera
Kona : Powder Science and Technology in Japan|April 2, 2026
Outstanding Contributions to Aerosol Pulmonary Drug DeliveryAnthony J Hickey, Erik S Pena, Sara E Maloney Norcross
Nucleic Acids Research|November 7, 2023
To let go or not to let go: how ParA can impact the release of the chromosomal anchoring in Caulobacter crescentusStephanie G Puentes-Rodriguez, John D Norcross, Paola E Mera
Journal of Virology|March 1, 1994
Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent mannerJ Wang, C Jones, M Norcross, et al.
Pageof 49

Showing results (161-170 of 483) with videos related to

Sort By:
Pageof 49
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2022
A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and ComprehensibilityAri Gnanasakthy, Lindsey Norcross, Carla DeMuro Romano, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 6, 2023
A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)Ari Gnanasakthy, Courtney Levy, Lindsey Norcross, et al.
FEBS Letters|July 8, 1985
A somatic cell mutant with a kinetically altered 3-hydroxy-3-methylglutaryl coenzyme A reductaseM Sinensky, J Logel, R Schnitzer-Polokoff, et al.
Journal of Virology|March 1, 1991
Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactionsL N Callahan, M Phelan, M Mallinson, et al.
Spine|May 20, 1999
Intraoperative somatosensory evoked potential findings in acute and chronic spinal canal compromiseK Norcross-Nechay, T Mathew, J W Simmons, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1992
Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4L N Callahan, G Roderiquez, M Mallinson, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
To let go or not to let go: how ParA can impact the release of the chromosomal anchoring in <i>Caulobacter crescentus</i>Stephanie G Puentes-Rodriguez, J D Norcross, Paola E Mera
Kona : Powder Science and Technology in Japan|April 2, 2026
Outstanding Contributions to Aerosol Pulmonary Drug DeliveryAnthony J Hickey, Erik S Pena, Sara E Maloney Norcross
Nucleic Acids Research|November 7, 2023
To let go or not to let go: how ParA can impact the release of the chromosomal anchoring in Caulobacter crescentusStephanie G Puentes-Rodriguez, John D Norcross, Paola E Mera
Journal of Virology|March 1, 1994
Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent mannerJ Wang, C Jones, M Norcross, et al.
Pageof 49